Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC

Fig. 1

WY-14,643 inhibits ccRCC cell proliferation and changes the morphology. a and b. 48 h after treatment with WY-14,643 at the indicated doses, the absorbance of ccRCC cells was examined at 450 nm. c and d., cell viability was calculated at the indicated time points after 200 µM WY-14,643 applied to ccRCC cells. e. HK2 cell viability was determined after specified doses of WY-14,643 were administered for 48 h. f. The changes in cell morphology were observed after administration of WY-14,643 for 48 h and photographed under an inverted microscope. Magnification, 100x. *P < 0.05, **P < 0.01. WY, WY-14,643

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X